Tyra Biosciences Inc (TYRA)
16.43
-0.89
(-5.14%)
USD |
NASDAQ |
May 28, 16:00
16.43
0.00 (0.00%)
After-Hours: 18:35
Tyra Biosciences Shareholders Equity (Quarterly): 389.88M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 389.88M |
| December 31, 2023 | 204.26M |
| September 30, 2023 | 222.17M |
| June 30, 2023 | 238.57M |
| March 31, 2023 | 248.79M |
| December 31, 2022 | 257.83M |
| September 30, 2022 | 267.76M |
| Date | Value |
|---|---|
| June 30, 2022 | 278.85M |
| March 31, 2022 | 291.18M |
| December 31, 2021 | 301.74M |
| September 30, 2021 | 309.73M |
| June 30, 2021 | -22.67M |
| December 31, 2020 | -13.64M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-22.67M
Minimum
Jun 2021
389.88M
Maximum
Mar 2024
228.80M
Average
257.83M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | 1.579M |
| iBio Inc | 24.86M |
| Theriva Biologics Inc | 34.12M |
| Oragenics Inc | 2.625M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 404.74M |
| Total Liabilities (Quarterly) | 14.86M |